Erythropoietin (EPO) and Semax Interaction
Erythropoietin (EPO) and Semax have an interaction requiring monitoring for interaction with 51% confidence. Both Erythropoietin (EPO) and Semax can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). These compounds primarily affect different organ systems.
Compound Profiles
Erythropoietin (EPO)
EPO | Red Blood Cell Stimulating Hormone
EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production.
View full profileSemax
Synthetic ACTH Analog | Nootropic & Neuroprotective Peptide
Rapidly increases BDNF levels, modulates dopaminergic and serotonergic systems, and achieves direct brain delivery through olfactory transport with 0.093% blood-brain barrier penetration (vs 0.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Erythropoietin (EPO) with Semax?
Yes, but with caution. Both Erythropoietin (EPO) and Semax can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). Regular monitoring is advised.
Is Erythropoietin (EPO) and Semax safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: blood pressure raising. Monitor accordingly.
What are the interactions between Erythropoietin (EPO) and Semax?
Both Erythropoietin (EPO) and Semax can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time Erythropoietin (EPO) and Semax?
Erythropoietin (EPO) has a half-life of 4-12 hours (IV), ~25 hours (SubQ) and Semax has a half-life of 0.5-2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.